ACLARION, INC. Cash Equivalents, at Carrying Value
ACLARION, INC. (ACON) had Cash Equivalents, at Carrying Value of $15.71 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash Equivalents, at Carrying Value $15.71M.
- 2026-03-31: Cash Equivalents, at Carrying Value $18.75M.
- 2025-12-31: Cash Equivalents, at Carrying Value $11.77M.
- 2025-09-30: Cash Equivalents, at Carrying Value $11.06M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $15.71M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $18.75M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $11.77M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $11.06M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $11.95M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $13.37M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-18 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 |
| 2023-12-31 | $0.00 10-K · filed 2025-04-09 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-25 |
| 2023-03-31 | $0.00 10-Q · filed 2023-07-03 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2021-12-31 | $0.00 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |